688366 昊海生科
已收盘 12-17 15:00:00
资讯
新帖
简况
昊海生科（688366）披露作废2021年A股限制性股票激励计划部分已授予但尚未归属的限制性股票，12月15日股价下跌2.51%
证券之星 · 12-15 18:02
昊海生科（688366）披露作废2021年A股限制性股票激励计划部分已授予但尚未归属的限制性股票，12月15日股价下跌2.51%
押注连亏企业 昊海生科“赌”新赛道
市场资讯 · 12-14 23:51
押注连亏企业 昊海生科“赌”新赛道
昊海生科切入生物羊膜赛道：标的业绩亏损、系实控人投资企业
市场资讯 · 12-14
昊海生科切入生物羊膜赛道：标的业绩亏损、系实控人投资企业
昊海生科(688366.SH)拟购买瑞济生物19.8%股权
智通财经 · 12-12
昊海生科(688366.SH)拟购买瑞济生物19.8%股权
昊海生科将以3840万元收购江西瑞集生物工程19.8%股权
美股速递 · 12-12
昊海生科将以3840万元收购江西瑞集生物工程19.8%股权
昊海生科（688366）披露翌日披露报表，12月12日股价上涨0.18%
证券之星 · 12-12
昊海生科（688366）披露翌日披露报表，12月12日股价上涨0.18%
昊海生科回购5.1万股 金额136万港元
财中社 · 12-11
昊海生科回购5.1万股 金额136万港元
昊海生科（688366）披露翌日披露报表，12月10日股价下跌1.91%
证券之星 · 12-10
昊海生科（688366）披露翌日披露报表，12月10日股价下跌1.91%
昊海生科（688366）披露回购H股股份进展，12月08日股价上涨0.1%
证券之星 · 12-08
昊海生科（688366）披露回购H股股份进展，12月08日股价上涨0.1%
昊海生科（688366）披露翌日披露报表，12月05日股价上涨0.66%
证券之星 · 12-05
昊海生科（688366）披露翌日披露报表，12月05日股价上涨0.66%
昊海生科（688366）披露购回H股股份情况，12月04日股价下跌0.35%
证券之星 · 12-04
昊海生科（688366）披露购回H股股份情况，12月04日股价下跌0.35%
昊海生科（688366）披露购回H股股份进展，12月2日股价下跌0.77%
证券之星 · 12-02
昊海生科（688366）披露购回H股股份进展，12月2日股价下跌0.77%
昊海生科（688366）发布召开2025年第三季度业绩说明会公告，11月28日股价上涨0.79%
证券之星 · 11-28
昊海生科（688366）发布召开2025年第三季度业绩说明会公告，11月28日股价上涨0.79%
昊海生科（688366）披露H股购回进展，11月26日股价下跌2.32%
证券之星 · 11-26
昊海生科（688366）披露H股购回进展，11月26日股价下跌2.32%
昊海生科（688366）披露H股购回进展，11月24日股价上涨0.94%
证券之星 · 11-24
昊海生科（688366）披露H股购回进展，11月24日股价上涨0.94%
每周股票复盘：昊海生科（688366）五日累计购回逾62万股H股
证券之星 · 11-23
每周股票复盘：昊海生科（688366）五日累计购回逾62万股H股
昊海生科（688366）披露回购H股股份进展，11月21日股价下跌2.38%
证券之星 · 11-21
昊海生科（688366）披露回购H股股份进展，11月21日股价下跌2.38%
昊海生科（688366）披露回购H股进展，11月20日股价下跌0.36%
证券之星 · 11-20
昊海生科（688366）披露回购H股进展，11月20日股价下跌0.36%
上海昊海生科完成对子公司剩余20%股权的收购
投资观察 · 11-20
上海昊海生科完成对子公司剩余20%股权的收购
昊海生科（688366）披露回购H股股份进展，11月19日股价下跌0.87%
证券之星 · 11-19
昊海生科（688366）披露回购H股股份进展，11月19日股价下跌0.87%
暂无数据
公司概况
公司名称：
上海昊海生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-10-30
主营业务：
上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。
发行价格：
89.23
{"stockData":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":44.59,"timestamp":1765954800000,"preClose":44.45,"halted":0,"volume":771221,"delay":0,"changeRate":0.0031,"floatShares":194000000,"shares":233000000,"eps":1.652,"marketStatus":"已收盘","change":0.14,"latestTime":"12-17 15:00:00","open":44.3,"high":44.76,"low":44.13,"amount":34288900,"amplitude":0.0142,"askPrice":44.61,"askSize":20,"bidPrice":44.59,"bidSize":7,"shortable":0,"etf":0,"ttmEps":1.652,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":44.45,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":48.9,"lowLimit":40.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232581095,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":26.991525,"roe":"5.39%","epsLYR":1.8,"committee":-0.268817,"marketValue":10371000000,"turnoverRate":0.004,"status":0,"afterMarket":{"amount":0,"volume":0,"close":44.59,"buyVolume":0,"sellVolume":0,"time":1765956837768,"indexStatus":"已收盘 12-17 15:30:00","preClose":44.45},"hkstockBrief":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":24.9,"timestamp":1765958890006,"preClose":24.88,"halted":0,"volume":325100,"delay":0,"premium":"-49.47"},"floatMarketCap":8653000000},"requestUrl":"/m/hq/s/688366/tweets","defaultTab":"tweets","newsList":[{"id":"2591617996","title":"昊海生科（688366）披露作废2021年A股限制性股票激励计划部分已授予但尚未归属的限制性股票，12月15日股价下跌2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591617996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591617996?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:02","pubTimestamp":1765792951,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，昊海生科报收于44.65元，较前一交易日下跌2.51%，最新总市值为103.85亿元。公司近日发布公告称，上海昊海生物科技股份有限公司于2025年12月12日召开第六届董事会第六次会议，审议通过作废2021年A股限制性股票激励计划部分已授予但尚未归属的限制性股票的议案。因预留授予部分第二个归属期届满，未能归属的限制性股票作废失效，合计作废225,002股。本次作废完成后，该激励计划实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500023704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","159982","399300","BK0239"],"gpt_icon":0},{"id":"2591667101","title":"押注连亏企业 昊海生科“赌”新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2591667101","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591667101?lang=zh_cn&edition=full","pubTime":"2025-12-14 23:51","pubTimestamp":1765727460,"startTime":"0","endTime":"0","summary":" 继完成对新产业眼科的全资控股后，昊海生科再次出手。昊海生科近日发布公告称，拟以自有资金3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司846.61万股股份，占瑞济生物总股本的19.8%，借此切入生物羊膜这一高价值医疗器械赛道。 收购背后，是昊海生科主营业务的增长困境。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-14/doc-inhauuyx3049629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2591663012","title":"昊海生科切入生物羊膜赛道：标的业绩亏损、系实控人投资企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663012","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663012?lang=zh_cn&edition=full","pubTime":"2025-12-14 19:59","pubTimestamp":1765713540,"startTime":"0","endTime":"0","summary":" 营收、净利双降之下，昊海生科拟布局生物羊膜。 昊海生科表示，公司通过投资标的公司，并获取标的公司产品在中国境内经销权，切入生物羊膜这一高价值医疗器械赛道，有效补充公司现有的产品组合，拓展眼科与骨科领域的业务覆盖。 昊海生科也提示风险称，本次交易未设置业绩承诺或对赌安排，如瑞济生物业绩下滑或不达预期，则不存在交易对价调整或股份回购等机制，故本次交易存在投资出现损失乃至投资资金无法收回的风险。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-12-14/doc-inhauqtc2773802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2590097485","title":"昊海生科(688366.SH)拟购买瑞济生物19.8%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2590097485","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590097485?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:16","pubTimestamp":1765545414,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生科 发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，包括肌腱损伤后的修复、眼表烧伤创伤及损害创面的修复、泪道阻塞探通后的植入和支撑等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"1101447236","title":"昊海生科将以3840万元收购江西瑞集生物工程19.8%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1101447236","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101447236?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:31","pubTimestamp":1765542674,"startTime":"0","endTime":"0","summary":"昊海生科将以3840万元收购江西瑞集生物工程19.8%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2590577922","title":"昊海生科（688366）披露翌日披露报表，12月12日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590577922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590577922?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:59","pubTimestamp":1765533552,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，昊海生科报收于45.8元，较前一交易日上涨0.18%，最新总市值为106.52亿元。该股当日开盘45.82元，最高45.82元，最低44.88元，成交额达1.19亿元，换手率为1.36%。公司近日发布公告称，上海昊海生物科技有限公司于2025年12月11日提交翌日披露报表，确认当日购回51,000股H股，每股价格介乎26.5至26.66港元，总代价1,356,366港元。该等股份拟注销且不作为库存股持有。此次购回依据2025年6月10日通过的授权进行，累计已购回2,343,000股，占当时已发行股份的5.9859%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200029171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2590932592","title":"昊海生科回购5.1万股 金额136万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590932592","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590932592?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:57","pubTimestamp":1765447020,"startTime":"0","endTime":"0","summary":"昊海生科（688366/06826）发布公告，2025年12月11日，公司回购股份5.1万股，回购金额为136万港元。根据回购授权的决议，公司可回购的股份总数为391万股，已回购股份234万股，占回购授权决议通过时已发行股份的5.9859%。 2025年前三季度，昊海生科实现收入18.99亿元，归母净利润3.05亿元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-11/doc-inhamnyf8127132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2590839985","title":"昊海生科（688366）披露翌日披露报表，12月10日股价下跌1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590839985","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590839985?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:51","pubTimestamp":1765360285,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，昊海生科报收于47.32元，较前一交易日下跌1.91%，最新总市值为110.06亿元。该股当日开盘48.34元，最高48.34元，最低47.29元，成交额达4222.71万元，换手率为0.46%。公司近日发布公告称，上海昊海生物科技有限公司于2025年12月9日提交翌日披露报表，报告显示当日购回H股103,300股，每股购回价介于26.8至27.28港元之间，总代价为2,782,052港元。截至2025年12月9日，公司累计购回股份总数为2,255,500股，占购回授权通过当日已发行股份的5.7624%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000028966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2589529339","title":"昊海生科（688366）披露回购H股股份进展，12月08日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589529339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589529339?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187547,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，昊海生科报收于48.91元，较前一交易日上涨0.1%，最新总市值为113.76亿元。该股当日开盘48.86元，最高49.18元，最低48.75元，成交额达2215.87万元，换手率为0.23%。公司近日发布公告称，上海昊海生物科技股份有限公司于2025年12月5日提交翌日披露报表，确认当日购回30,500股H股，每股价格介乎27.26至27.50港元，总代价837,034港元。该等股份拟注销，不持有库存股份。本次购回后30日内不得发行新股或出售库存股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2589895393","title":"昊海生科（688366）披露翌日披露报表，12月05日股价上涨0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589895393","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589895393?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:49","pubTimestamp":1764928166,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，昊海生科报收于48.86元，较前一交易日上涨0.66%，最新总市值为113.64亿元。该股当日开盘48.87元，最高48.87元，最低48.15元，成交额达1456.55万元，换手率为0.15%。公司近日发布公告称，上海昊海生物科技有限公司于2025年12月4日提交翌日披露报表，确认当日购回H股64,000股，每股价格介乎27.10至27.34港元，总代价1,742,418港元。该等股份拟注销，不作为库存股持有。本次购回依据2025年6月10日通过的授权进行，累计已购回2,019,500股，占当时已发行股份的5.1594%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2588740007","title":"昊海生科（688366）披露购回H股股份情况，12月04日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588740007","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588740007?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:28","pubTimestamp":1764840515,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，昊海生科报收于48.54元，较前一交易日下跌0.35%，最新总市值为112.89亿元。该股当日开盘48.86元，最高48.88元，最低48.28元，成交额达1701.36万元，换手率为0.18%。公司近日发布公告称，上海昊海生物科技有限公司于2025年12月3日提交翌日披露报表，报告显示公司于当日购回91,300股H股，每股购回价介乎27.24至27.50港元，总代价为2,497,312港元。该等股份拟注销，不持有库存股份。购回授权于2025年6月10日获决议通过，累计已购回股份占当时已发行股份的4.9959%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400027167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2588857031","title":"昊海生科（688366）披露购回H股股份进展，12月2日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588857031","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588857031?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:54","pubTimestamp":1764669287,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，昊海生科报收于49.01元，较前一交易日下跌0.77%，最新总市值为113.99亿元。该股当日开盘49.45元，最高49.5元，最低48.9元，成交额达2124.12万元，换手率为0.22%。公司近日发布公告称，上海昊海生物科技有限公司于2025年12月1日提交翌日披露报表，显示当日购回74,900股H股，每股购回价介于27.38至27.70港元，总代价2,061,504港元。该等股份拟注销。购回授权于2025年6月10日获决议通过，累计已购回股份占授权当日已发行股份的4.5018%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200027302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2586802783","title":"昊海生科（688366）发布召开2025年第三季度业绩说明会公告，11月28日股价上涨0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586802783","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586802783?lang=zh_cn&edition=full","pubTime":"2025-11-28 17:48","pubTimestamp":1764323327,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，昊海生科报收于49.5元，较前一交易日上涨0.79%，最新总市值为115.13亿元。该股当日开盘49.25元，最高49.55元，最低48.88元，成交额达2062.5万元，换手率为0.22%。公司近日发布公告称，将于2025年12月5日15:00-16:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司经营情况并回答投资者提问。投资者可于2025年12月4日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后，投资者可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800026398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2586258598","title":"昊海生科（688366）披露H股购回进展，11月26日股价下跌2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258598?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:51","pubTimestamp":1764150705,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，昊海生科报收于49.3元，较前一交易日下跌2.32%，最新总市值为114.66亿元。公司近日发布公告称，上海昊海生物科技有限公司于2025年11月25日提交翌日披露报表，报告显示当日购回93,700股H股，每股购回价介乎27.5至27.8港元，总代价为2,591,834港元。该等股份拟注销，不持有库存股份。本次购回依据2025年6月10日通过的授权进行，累计已购回1,402,600股，占当时已发行股份的3.5834%。购回后30日内不会发行新股或出售库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2585680074","title":"昊海生科（688366）披露H股购回进展，11月24日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585680074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585680074?lang=zh_cn&edition=full","pubTime":"2025-11-24 18:00","pubTimestamp":1763978446,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，昊海生科报收于49.33元，较前一交易日上涨0.94%，最新总市值为114.73亿元。该股当日开盘48.96元，最高49.76元，最低48.9元，成交额达2746.34万元，换手率为0.29%。公司近日发布公告称，上海昊海生物科技有限公司于2025年11月21日提交翌日披露报表，报告显示当日购回206,000股H股，每股价格介于26.88至27.5港元之间，总代价为5,592,660港元。本次购回依据2025年6月10日通过的购回授权进行，占当时已发行股份的0.0901%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"gpt_icon":0},{"id":"2585105076","title":"每周股票复盘：昊海生科（688366）五日累计购回逾62万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105076?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:18","pubTimestamp":1763842693,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，昊海生科报收于48.87元，较上周的52.2元下跌6.38%。本周关注点公司公告汇总：昊海生科连续五日购回H股，累计购回627,200股，总代价约1717万港元。公司公告汇总上海昊海生物科技股份有限公司于2025年11月17日购回H股121,500股，每股价格介乎27.3至27.82港元，总代价3,358,184港元。该等股份拟注销，不持有库存股份。截至当日，已发行H股总数维持38,529,240股。H股和A股已发行股份总数分别为38,529,240股和190,203,760股，库存股数量无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2585253111","title":"昊海生科（688366）披露回购H股股份进展，11月21日股价下跌2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585253111","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585253111?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:21","pubTimestamp":1763720509,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，昊海生科报收于48.87元，较前一交易日下跌2.38%，最新总市值为113.66亿元。公司近日发布公告称，已于2025年11月20日购回H股47,100股，每股价格介乎27.10至27.54港元，总代价1,287,612港元。此次购回的股份拟予以注销，公司不持有库存股份。本次购回依据2025年6月10日通过的授权进行，占当时已发行股份的2.7255%。购回后30日内，公司不会发行新股或出售库存股份。H股总数维持在38,529,240股，A股总数维持在190,203,760股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100029171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2584873681","title":"昊海生科（688366）披露回购H股进展，11月20日股价下跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584873681","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584873681?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:48","pubTimestamp":1763632106,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，昊海生科报收于50.06元，较前一交易日下跌0.36%，最新总市值为116.43亿元。该股当日开盘50.24元，最高50.51元，最低49.86元，成交额达2844.25万元，换手率为0.29%。公司近日发布公告称，上海昊海生物科技有限公司于2025年11月19日提交翌日披露报表，报告显示公司于当日购回74,900股H股，每股价格介乎27.20至27.50港元，总代价为2,048,322港元。截至2025年11月19日，公司已累计购回部分股份，且购回后30天内不会发行新股或出售库存股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000026944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"1160273498","title":"上海昊海生科完成对子公司剩余20%股权的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1160273498","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160273498?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:08","pubTimestamp":1763572127,"startTime":"0","endTime":"0","summary":"11月7日 - 上海昊海生科有限公司（688366.SS）宣布，已以7400万元人民币收购其子公司的剩余20%股权。进一步公司覆盖信息：688366.SS","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2584191406","title":"昊海生科（688366）披露回购H股股份进展，11月19日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584191406","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584191406?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:33","pubTimestamp":1763544831,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，昊海生科报收于50.24元，较前一交易日下跌0.87%，最新总市值为116.85亿元。该股当日开盘50.83元，最高51.0元，最低50.01元，成交额达2754.34万元，换手率为0.28%。公司近日发布公告称，上海昊海生物科技有限公司于2025年11月18日提交翌日披露报表，报告显示公司于当日购回177,700股H股，每股价格介乎27.4至27.7港元，总代价为4,888,144港元。该等股份拟注销，不作为库存股持有。截至2025年11月18日，公司已发行H股总数维持38,529,240股，无变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900028200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765974159047,"stockEarnings":[{"period":"1week","weight":-0.0786},{"period":"1month","weight":-0.1485},{"period":"3month","weight":-0.1736},{"period":"6month","weight":-0.0864},{"period":"1year","weight":-0.2886},{"period":"ytd","weight":-0.252}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海昊海生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2019-10-30","address":"上海市松江区松江工业区洞泾路5号","registeredCapital":"23258万元","survey":" 上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。","listedPrice":89.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生科,688366,昊海生科股票,昊海生科股票老虎,昊海生科股票老虎国际,昊海生科行情,昊海生科股票行情,昊海生科股价,昊海生科股市,昊海生科股票价格,昊海生科股票交易,昊海生科股票购买,昊海生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}